Shahram Seyedin-Noor, founder and Managing Partner of Civilization Ventures. See contact routes.
Shahram Seyedin-Noor, founder and Managing Partner of Civilization Ventures, invests $100k–$5M checks into pre-seed and seed-stage biotech companies, primarily in diagnostics, genomics, AI-native health software, and longevity. His distinctive thesis centers on "mentor capital" for seasoned and first-time scientific founders—especially young PhDs and postdocs from elite institutions—focusing on overlooked areas where rigorous science can create category-defining firms. Notable portfolio companies and exits include BillionToOne (IPO), Omada Health (IPO), Foresight Diagnostics (acquired by Natera), Rocket Pharma (Nasdaq-listed), Aspect Biosystems, and Curai Health.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in San Francisco when building a target list.
Investors like Shahram Seyedin-Noor · Full investor directory · Investor access · Company funding database